FDA expands Susvimo’s indications to include diabetic retinopathy

Published on May 22, 2025
Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with just one refill every 9 months
Continue reading on website
Other news

Hypoglycemia may promote a breakdown of the blood-retinal barrier, study finds

May 22, 2025
New research reveals how low blood sugar can damage the retina in diabetes, highlighting potential treatments targeting specific proteins to prevent vision loss.

NAION Shown to Increase Risk of Ischemic Stroke

May 23, 2025
Carotid artery stenosis remains a major risk factor for large-vessel stroke, and development of this may accelerate carotid plaque buildup, leading to future strokes.Photo: Cleveland Clinic. Click image to enlarge. Hypoperfusion to the optic nerve head—the presumed culprit in nonarteritic anterior ischemic optic neuropathy (NAION)—and thromboembolic ischemic strokes are diff